In February, QUOD launched the first QUOD Innovation Competition in partnership with the charity Live Life Give Life, Alexion, and the European Society of Transplantation (ESOT).
The final of the QUOD Innovation Competition 2025 took place during the Young Academics Masterclass at the ESOT Congress in London on 28 June.
We received a strong pool of high-quality applications, which were evaluated based on criteria including originality of the project, patient impact, and clinical translation.
Six shortlisted researchers competed for two awards of up to £5000-worth of QUOD samples for their research projects.
The finalists were…
- Peishan Wang
Spatial-integrated temporal graph neural network model for early liver micro-injury and immunoabnormalities prediction in DCD liver donation - Maithili Mehta
Decoding the Impact of cytosorb therapy during kidney normothermic machine perfusion using single-cell transcriptomics - Euan Bright
The role of kynurenine 3-monooxygenase in preventing ischaemic cholangiopathy following liver transplantation - Sarah Fawaz
Not all diabetic donors are the same: identifying differential risk profiles for transplant outcomes - Mayara Ramos
Evaluation of the donor’s hormonal profile according to sex and age - David Baird
Biomarkers of cell senescence and patient outcomes in kidney transplantation
The judging panel, comprising Prof Rutger Ploeg (QUOD Biobank), Karen Rockell (UKODTRN and QUOD Biobank), Dr Liset Pengel (Erasmus MC Transplant Institute), and Dr Luke Yates (Live Life Give Life), were blown away by the high standards of the research proposed.
After much deliberation, the winners were announced.
Huge congratulations to our two winners, David Baird and Euan Bright! We cannot wait to get started supporting your research and we patiently await the results.
A huge thank you to everyone who applied. We are extremely grateful to Live Life Give Life and Alexion for sponsoring the Innovation Competition, and to ESOT for hosting the final.
